(Q72561855)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7862945%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

title

Nonlinear relationship between circulating concentrations of reduced haloperidol and haloperidol: evaluation of possible mechanisms (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7862945%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference

D W Eyles

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7862945%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

T J Stedman

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7862945%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

S M Pond

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7862945%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

publication date

1 October 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7862945%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

number of pages

6

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7862945%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

volume

116

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7862945%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7862945%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

161-166

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7862945%20AND%20SRC:MED&resulttype=core&format=json

Research diagnostic criteria: rationale and reliability

27 October 2019

cites work

1 reference

12 December 2020

Stereospecific reduction of haloperidol in human tissues

1 reference

12 December 2020

Reduced Haloperidol/Haloperidol ratio and clinical outcome in schizophrenia: Preliminary evidences

1 reference

12 December 2020

Studies on serum protein binding of haloperidol

1 reference

12 December 2020

Use of antisera in the isolation of human specific conjugates of haloperidol

1 reference

12 December 2020

Interconversions between haloperidol and reduced haloperidol in schizophrenic patients and guinea pigs: a steady-state study

1 reference

12 December 2020

Haloperidol and reduced haloperidol plasma levels in selected schizophrenic patients

1 reference

12 December 2020

Determination of haloperidol and reduced haloperidol in the plasma and blood of patients on depot haloperidol

1 reference

12 December 2020

Pharmacodynamics and pharmacokinetics of haloperidol and reduced haloperidol in schizophrenic patients

1 reference

12 December 2020

Haloperidol metabolism in psychiatric patients: importance of glucuronidation and carbonyl reduction

1 reference

12 December 2020

Plasma haloperidol and clinical response: a role for reduced haloperidol in antipsychotic activity?

1 reference

12 December 2020

Comparison of haloperidol and reduced haloperidol plasma levels in four different ethnic populations.

1 reference

12 December 2020

Total and free plasma neuroleptic levels in schizophrenic patients

1 reference

12 December 2020

Factors Affecting the Clinical Response to Haloperidol Therapy in Schizophrenia

1 reference

12 December 2020

Dose-dependent reduced haloperidol/haloperidol ratios in schizophrenic patients

1 reference

12 December 2020

Serum haloperidol concentration and clinical response in schizophrenia

1 reference

12 December 2020

Antischizophrenic drugs: Differential plasma protein binding and therapeutic activity

1 reference

12 December 2020

Reduced haloperidol plasma concentration and clinical response in acute exacerbations of schizophrenia

1 reference

12 December 2020

Partition coefficients of dopamine antagonists in brain membranes and liposomes

1 reference

12 December 2020

Biliary excretion of reduced haloperidol glucuronide

1 reference

12 December 2020

Total and free serum haloperidol levels in schizophrenic patients and the effect of age thioridazine and fatty acid on haloperidol-serum protein binding in vitro

1 reference

12 December 2020

Protein measurement with the Folin phenol reagent

1 reference

12 December 2020

Haloperidol plasma levels and clinical response: a therapeutic window relationship

1 reference

12 December 2020

Haloperidol and reduced haloperidol concentrations in plasma and red blood cells from chronic schizophrenic patients

1 reference

12 December 2020

Pharmacokinetics of haloperidol

1 reference

12 December 2020

Interconversion between haloperidol and reduced haloperidol in humans

1 reference

12 December 2020

Reduced haloperidol/haloperidol ratios in plasma: polymorphism in Japanese psychiatric patients.

1 reference

12 December 2020

Haloperidol blood levels and clinical effects

1 reference

12 December 2020

Errors in interpretation of data from equilibrium dialysis protein binding experiments

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02245058

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7862945%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference